Lapi Francesco, Marconi Ettore, Cricelli Iacopo, Rossi Alessandro, Mastronuzzi Tecla, Gabutti Giovanni, Cricelli Claudio
Health Search, Italian College of General Practitioners and Primary Care, Via del Sansovino 179, 50142 Florence, Italy.
Genomedics SRL, 50141 Florence, Italy.
Infect Dis Rep. 2024 Sep 2;16(5):870-879. doi: 10.3390/idr16050068.
: In recent years, Europe has experienced a significant increase in pertussis cases. One reason behind this rise is the decline in diphtheria-tetanus-pertussis (dTap) booster coverage among adults. Currently, Italy lacks a reliable monitoring system to track pertussis infections and vaccine coverage among adults. We therefore evaluated the reliability of a primary care framework to respond to this need. : Using an Italian primary care database for individuals aged 15 or above, we determined the pertussis infection notification rate and dTap vaccine/booster coverage for the timeframe of 2009-2022. : In the overall population, we obtained a lifetime occurrence rate of pertussis infections of 7.52 per 10,000 individuals. The annual incidence rates of pertussis infections ranged from 0.008 to 0.001 per 10,000 person-years between 2009 and 2022. A rising trend in dTap vaccine coverage rate (ranging from 8.72 to 16.54 vaccines per 10,000 individuals) was observed during the same period. Notably, those aged 65 or older, smokers, and/or individuals with immunodeficiencies were more likely to receive the dTap vaccine compared to the general population. : Given the organization of the Italian public health system, this primary care network might act as a reliable epidemiological monitoring system to keep track of pertussis infections and dTap vaccine coverage in adults. Pertussis cases were underreported, and there was a low uptake of vaccines and boosters. Therefore, it is crucial to closely monitor pertussis notifications and dTap administrations and develop intervention strategies at the national level to enhance vaccine-related prevention.
近年来,欧洲百日咳病例显著增加。这一增长背后的一个原因是成人白喉-破伤风-百日咳(dTap)加强疫苗接种覆盖率下降。目前,意大利缺乏一个可靠的监测系统来追踪成人百日咳感染情况和疫苗接种覆盖率。因此,我们评估了一个初级保健框架满足这一需求的可靠性。
利用一个针对15岁及以上人群的意大利初级保健数据库,我们确定了2009年至2022年期间百日咳感染报告率以及dTap疫苗/加强疫苗接种覆盖率。
在总体人群中,我们得出百日咳感染的终生发生率为每10000人中有7.52例。2009年至2022年期间,百日咳感染的年发病率在每10000人年0.008至0.001例之间。同期观察到dTap疫苗接种覆盖率呈上升趋势(从每10000人8.72剂至16.54剂)。值得注意的是,与普通人群相比,65岁及以上人群、吸烟者和/或免疫功能低下者更有可能接种dTap疫苗。
鉴于意大利公共卫生系统的组织架构,这个初级保健网络可能充当一个可靠的流行病学监测系统,以追踪成人百日咳感染情况和dTap疫苗接种覆盖率。百日咳病例报告不足,疫苗和加强疫苗的接种率较低。因此,密切监测百日咳报告和dTap疫苗接种情况并在国家层面制定干预策略以加强与疫苗相关的预防措施至关重要。